New remedy for rheumatoid arthritis will be offered by SUS
People with rheumatoid arthritis may have another medication to treatment in the Unified Health System (SUS): tofacitinibe citrate. The SUS has up to 180 days from the last Thursday (2) to make the medicine available in the country.
The remedy is indicated for adults with active, moderate to severe rheumatoid arthritis, with an inadequate response to one or more disease-modifying drugs. Rheumatoid arthritis is an autoimmune, inflammatory, systemic, and chronic disease. In Brazil, a 2004 study showed a prevalence of 0.46%, representing almost one million people with this disease.
The incidence of rheumatoid arthritis disease increases with age and the highest peak is between 30 and 50 years. The female sex is the most affected by the disease, about two to three times in relation to the male sex. If untreated, 20% to 30% of people with rheumatoid arthritis are permanently unable to perform their activities after about three years from diagnosis.
Symptoms are divided between typical and atypical. In the first group we included heartburn or heartburn (retrosternal burning) and regurgitation. In the second group we have feelings of food impaction, chronic cough, asthma, pulmonary fibrosis, pneumonia, chest pain, laryngitis, sinusitis, otitis, ulcers, hoarseness, hawking, halitosis and dental erosion.
The number of cases caused by a mysterious disease in Bahia, which causes intense muscle pain and black-colored urine, has increased unexpectedly. According to the Secretary of Health of the State of Bahia (Sesab), at least 52 people present the symptoms of the disease, which is treated as "acute myalgia (pain) to clarify".